MedTrace Logo

Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury

NCT04412369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2024-07-19

No results posted yet for this study

Summary

Cardiovascular involvement in coronavirus disease-2019 (COVID-19) encompasses a wide range of vascular and myocardial pathologies, including both acute and long-term sequelae. The MIIC-MI study aims to investigate mechanisms of cardiac injury in COVID-19 using multi-modality imaging and immunophenotyping to better understand the link with adverse patient outcomes.

Conditions

Interventions

DIAGNOSTIC_TEST

Non-invasive cardiac imaging

Cardiac MRI ± CT coronary angiography ± Cardiac PET/MRI (68Ga-DOTATATE or 18F-FDG)

Sponsors & Collaborators

  • Cambridge University Hospitals NHS Foundation Trust

    collaborator OTHER

  • British Heart Foundation

    collaborator OTHER

  • Wellcome Trust

    collaborator OTHER

  • University of Cambridge

    lead OTHER

Principal Investigators

  • Jason M Tarkin, MBBS, PhD · University of Cambridge

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2022-12-01
Completion
2023-08-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04412369 on ClinicalTrials.gov